GL1X · GenesisL1 explorer

Research workbench

Structure of human plasma kallikrein protease domain with inhibitor

Analyse Structure of human plasma kallikrein protease domain with inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6O1S
Type
protein
Length
239 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P03952
Ligands
7SD, PO4

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
E—protein239—P03952

Ligands and binding sites

  • 7SD · N-[(6-amino-2,4-dimethylpyridin-3-yl)methyl]-1-({4-[(1H-pyrazol-1-yl)methyl]phenyl}methyl)-1H-pyrazole-4-carboxamide · ligand · chains E
  • PO4 · Phosphate ion · ion · chains E
  • EDO · 1,2-ethanediol · additive · chains E

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6O1S · Structure of human plasma kallikrein protease domain with inhibitor · the same entry in another collection · chain E against E, TM-score 1.00
  • P03952 · AlphaFold monomer V2.0 prediction for plasma kallikrein (P03952) · a predicted model of the same protein · chain E against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.